Indian Pharma Could Gain Market Share Amid US Tariffs, Says JPMorgan
7 Articles
7 Articles


Indian pharma firms may gain market share due to higher US tariffs: Report
Mumbai: Indian pharma companies may stand to gain market share due to the potential impact of US tariffs, according to a JPMorgan report. Essentially, Indian pharmaceutical companies have the potential to gain market share at the expense of their global competitors due to their superior cost competitiveness, JPMorgan said. In an expert call, the brokerage also pointed out that the possibility of manufacturing relocation by pharmaceutical compani…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage